Growth Capitalist (https://growthcapitalist.com/author/moriarty/page/182/)
uSell.com Inc. (USELD) announced that it has raised $1,500,000 in a Common Stock transaction. The common stock was sold at $3.00 per share, an approximate 28% discount to the market price ($4.15) of USELD at deal announcement. The transaction is expected to close by 02/12/2014. via PlacementTracker.
Southern First Bancshares, Inc. (SFST) announced that it has raised $6,175,000 in a Common Stock transaction. The common stock was sold at $13.00 per share, an approximate 2% discount to the market price ($13.30) of SFST at deal announcement. Sandler O'Neill & Partners, L.P. acted as Financial Advisor on the transaction. The investment advisor was EJF Capital. Issuer counsel was Nelson Mullins Riley & Scarborough, LLP.
Idenix Pharmaceuticals Inc. (IDIX) announced that it has raised $106,731,567 in a Registered Direct transaction. The common stock was sold at $6.50 per share, an approximate 5% discount to the market price ($6.87) of IDIX at deal announcement. The investor was Baupost Group. Issuer counsel was Wilmer Cutler Pickering Hale & Dorr and investor counsel was Ropes & Gray. The transaction is expected to close on January 31, 2014.
MYOS Corporation (MYOS) announced that it has raised $4,735,002 in a Units (Common Stock + Warrants) transaction. The common stock was sold at $0.15 per share, an approximate 10% premium to the market price ($0.1365) of MYOS at deal announcement. A series of 15,783,347 Warrants with an exercise price of $0.30 per share (119.78% premium) were issued to the investors in this transaction. An additional series of 7,891,677 Warrants with an exercise price of $0.90 per share (559.34% premium) were issued to the investors in this transaction. Brean Capital acted as the exclusive agent on the transaction.
